RT Journal Article
SR Electronic
T1 Diffusion model enables quantitative CBF analysis of Alzheimer’s Disease
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.07.01.24309791
DO 10.1101/2024.07.01.24309791
A1 Shou, Qinyang
A1 Cen, Steven
A1 Chen, Nan-kuei
A1 Ringman, John M
A1 Wen, Junhao
A1 Kim, Hosung
A1 Wang, Danny JJ
A1 ,
YR 2024
UL http://medrxiv.org/content/early/2024/07/03/2024.07.01.24309791.abstract
AB Objectives Cerebral blood flow (CBF) measured by arterial spin labeling (ASL) is a promising biomarker for Alzheimer’s Disease (AD). ASL data from multiple vendors were included in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset. However, the M0 images were missing in Siemens ASL data, prohibiting CBF quantification. Here, we utilized a generative diffusion model to impute the missing M0 and validated generated CBF data with acquired data from GE.Methods A conditional latent diffusion model was trained to generate the M0 image and validate it on an in-house dataset (N=55) based on image similarity metrics, accuracy of CBF quantification, and consistency with the physical model. This model was then applied to the ADNI dataset (Siemens: N=211) to impute the missing M0 for CBF calculation. We further compared the imputed data (Siemens) and acquired data (GE) regarding regional CBF differences by AD stages, their classification accuracy for AD prediction, and CBF trajectory slopes estimated by a mixed effect model.Results The trained diffusion model generated the M0 image with high fidelity (Structural similarity index, SSIM=0.924±0.019; peak signal-to-noise ratio, PSNR=33.348±1.831) and caused minimal bias in CBF values (mean difference in whole brain is 1.07±2.12ml/100g/min). Both generated and acquired CBF data showed similar differentiation patterns by AD stages, similar classification performance, and decreasing slopes with AD progression in specific AD-related regions. Generated CBF data also improved accuracy in classifying AD stages compared to qualitative perfusion data.Interpretation/Conclusion This study shows the potential of diffusion models for imputing missing modalities for large-scale studies of CBF variation with AD.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported in part by the U.S. National Institute of Health under Grant R01-NS114382, R01-EB032169, R01-EB028297, R01-NS102220, U19-AG065169 and S10-OD032285.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The IRB of University of Southern California gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon request to the authors.The analysis data is publicly available at (adni.loni.usc.edu), code for this paper will be available upon publication.